25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Cardax Inc
Buy, Hold or Sell?

Let's analyze Cardax Inc together

I guess you are interested in Cardax Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cardax Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cardax Inc

I send you an email if I find something interesting about Cardax Inc.

1. Quick Overview

1.1. Quick analysis of Cardax Inc (30 sec.)










1.2. What can you expect buying and holding a share of Cardax Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-12.71
Expected worth in 1 year
$-27.66
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-14.95
Return On Investment
-7,474,360.6%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0002 - $0.0002
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cardax Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-28.94 - $-20.07
Total Value Per Share
$-41.64 - $-32.77

2.2. Growth of Cardax Inc (5 min.)




Is Cardax Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$10.1m-$7.1m-$2.9m-29.4%

How much money is Cardax Inc making?

Current yearPrevious yearGrowGrow %
Making money-$7.3m-$5.7m-$1.5m-21.8%
Net Profit Margin-1,356.8%-804.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Cardax Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cardax Inc?

Welcome investor! Cardax Inc's management wants to use your money to grow the business. In return you get a share of Cardax Inc.

First you should know what it really means to hold a share of Cardax Inc. And how you can make/lose money.

Speculation

The Price per Share of Cardax Inc is $0.0002. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cardax Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cardax Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-12.71. Based on the TTM, the Book Value Change Per Share is $-3.74 per quarter. Based on the YOY, the Book Value Change Per Share is $-4.56 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cardax Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-6.30-3,149,785.8%-6.30-3,149,785.8%-6.35-3,173,168.5%-4.47-2,235,681.9%-4.95-2,473,660.5%
Usd Book Value Change Per Share-3.74-1,868,590.2%-3.74-1,868,590.2%-4.56-2,282,482.8%-1.61-803,736.6%-1.27-635,376.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-3.74-1,868,590.2%-3.74-1,868,590.2%-4.56-2,282,482.8%-1.61-803,736.6%-1.27-635,376.5%
Usd Price Per Share1.70-1.70-0.05-0.44-0.29-
Price to Earnings Ratio-0.27--0.27--0.01--0.09--0.05-
Price-to-Total Gains Ratio-0.45--0.45--0.01--0.23--0.24-
Price to Book Ratio-0.13--0.13--0.01--0.06--0.05-
Price-to-Total Gains Ratio-0.45--0.45--0.01--0.23--0.24-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0002
Number of shares5000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-3.74-1.61
Usd Total Gains Per Share-3.74-1.61
Gains per Quarter (5000000 shares)-18,685,901.59-8,037,366.23
Gains per Year (5000000 shares)-74,743,606.36-32,149,464.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-74743606-747436160-32149465-32149475
20-149487213-1494872220-64298930-64298940
30-224230819-2242308280-96448395-96448405
40-298974425-2989744340-128597860-128597870
50-373718032-3737180400-160747325-160747335
60-448461638-4484616460-192896790-192896800
70-523205245-5232052520-225046255-225046265
80-597948851-5979488580-257195719-257195730
90-672692457-6726924640-289345184-289345195
100-747436064-7474360700-321494649-321494660

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%2.08.00.020.0%2.08.00.020.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.010.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%2.08.00.020.0%2.08.00.020.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cardax Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.737-3.7370%-4.565+22%-1.607-57%-1.271-66%
Book Value Per Share---12.708-12.7080%-8.970-29%-6.535-49%-4.266-66%
Current Ratio--0.1060.1060%0.195-45%0.262-59%1.170-91%
Debt To Asset Ratio--8.1568.1560%4.566+79%4.556+79%4.134+97%
Debt To Equity Ratio----0%-0%-0%0.005-100%
Dividend Per Share----0%-0%-0%-0%
Eps---6.300-6.3000%-6.346+1%-4.471-29%-4.947-21%
Free Cash Flow Per Share---2.251-2.2510%-4.467+98%-2.994+33%-2.450+9%
Free Cash Flow To Equity Per Share--0.0000.0000%-0.280+180908%-0.076+48970%-0.035+22377%
Gross Profit Margin--1.0001.0000%1.0000%1.067-6%1.034-3%
Intrinsic Value_10Y_max---20.067--------
Intrinsic Value_10Y_min---28.936--------
Intrinsic Value_1Y_max---2.788--------
Intrinsic Value_1Y_min---3.446--------
Intrinsic Value_3Y_max---7.785--------
Intrinsic Value_3Y_min---9.942--------
Intrinsic Value_5Y_max---12.068--------
Intrinsic Value_5Y_min---15.937--------
Market Cap160.503-849900%1364277.2001364277.2000%40767.813+3246%356445.507+283%235201.389+480%
Net Profit Margin---13.568-13.5680%-8.041-41%-15.623+15%-7.911-42%
Operating Margin---5.920-5.9200%-5.735-3%-13.614+130%-6.907+17%
Operating Ratio--6.6836.6830%6.735-1%14.854-55%7.687-13%
Pb Ratio0.000+100%-0.134-0.1340%-0.006-96%-0.060-55%-0.047-65%
Pe Ratio0.000+100%-0.270-0.2700%-0.008-97%-0.086-68%-0.050-81%
Price Per Share0.000-849900%1.7001.7000%0.051+3246%0.444+283%0.293+480%
Price To Free Cash Flow Ratio0.000+100%-0.755-0.7550%-0.011-98%-0.189-75%-0.115-85%
Price To Total Gains Ratio0.000+100%-0.455-0.4550%-0.011-98%-0.226-50%-0.243-46%
Quick Ratio--0.0020.0020%0.028-93%0.139-99%1.033-100%
Return On Assets---5.131-5.1310%-2.831-45%-2.521-51%-3.689-28%
Return On Equity----0%-0%-0%-0.0170%
Total Gains Per Share---3.737-3.7370%-4.565+22%-1.607-57%-1.271-66%
Usd Book Value---10197996.000-10197996.0000%-7198849.000-29%-5244647.400-49%-4607428.300-55%
Usd Book Value Change Per Share---3.737-3.7370%-4.565+22%-1.607-57%-1.271-66%
Usd Book Value Per Share---12.708-12.7080%-8.970-29%-6.535-49%-4.266-66%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---6.300-6.3000%-6.346+1%-4.471-29%-4.947-21%
Usd Free Cash Flow---1806196.000-1806196.0000%-3584450.000+98%-2402755.000+33%-2346979.200+30%
Usd Free Cash Flow Per Share---2.251-2.2510%-4.467+98%-2.994+33%-2.450+9%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.280+180908%-0.076+48970%-0.035+22377%
Usd Market Cap160.503-849900%1364277.2001364277.2000%40767.813+3246%356445.507+283%235201.389+480%
Usd Price Per Share0.000-849900%1.7001.7000%0.051+3246%0.444+283%0.293+480%
Usd Profit---7312331.000-7312331.0000%-5716452.000-22%-4164388.800-43%-4727992.000-35%
Usd Revenue--538946.000538946.0000%710949.000-24%681270.200-21%355439.700+52%
Usd Total Gains Per Share---3.737-3.7370%-4.565+22%-1.607-57%-1.271-66%
 EOD+2 -6MRQTTM+0 -0YOY+18 -145Y+14 -1810Y+15 -18

3.3 Fundamental Score

Let's check the fundamental score of Cardax Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than0-13.568
Operating Margin (MRQ)Greater than0-5.920
Quick Ratio (MRQ)Greater than10.002
Current Ratio (MRQ)Greater than10.106
Debt to Asset Ratio (MRQ)Less than18.156
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-5.131
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Cardax Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Cardax Inc

Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is also developing CDX-101, an astaxanthin pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, with a target indication of severe hypertriglyceridemia; and CDX-301, a zeaxanthin pharmaceutical candidate for macular degeneration. Cardax, Inc. is based in Honolulu, Hawaii.

Fundamental data was last updated by Penke on 2024-08-31 22:39:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cardax Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cardax Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -1,356.8% means that $-13.57 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cardax Inc:

  • The MRQ is -1,356.8%. The company is making a huge loss. -2
  • The TTM is -1,356.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,356.8%TTM-1,356.8%0.0%
TTM-1,356.8%YOY-804.1%-552.7%
TTM-1,356.8%5Y-1,562.3%+205.5%
5Y-1,562.3%10Y-791.1%-771.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,356.8%-132.1%-1,224.7%
TTM-1,356.8%-212.2%-1,144.6%
YOY-804.1%-221.9%-582.2%
5Y-1,562.3%-373.2%-1,189.1%
10Y-791.1%-490.1%-301.0%
4.3.1.2. Return on Assets

Shows how efficient Cardax Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cardax Inc to the Biotechnology industry mean.
  • -513.1% Return on Assets means that Cardax Inc generated $-5.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cardax Inc:

  • The MRQ is -513.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -513.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-513.1%TTM-513.1%0.0%
TTM-513.1%YOY-283.1%-229.9%
TTM-513.1%5Y-252.1%-261.0%
5Y-252.1%10Y-368.9%+116.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-513.1%-11.1%-502.0%
TTM-513.1%-11.7%-501.4%
YOY-283.1%-11.2%-271.9%
5Y-252.1%-12.9%-239.2%
10Y-368.9%-14.4%-354.5%
4.3.1.3. Return on Equity

Shows how efficient Cardax Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cardax Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Cardax Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cardax Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-1.7%+1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.6%+13.6%
TTM--16.1%+16.1%
YOY--13.6%+13.6%
5Y--18.9%+18.9%
10Y-1.7%-19.1%+17.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cardax Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cardax Inc is operating .

  • Measures how much profit Cardax Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cardax Inc to the Biotechnology industry mean.
  • An Operating Margin of -592.0% means the company generated $-5.92  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cardax Inc:

  • The MRQ is -592.0%. The company is operating very inefficient. -2
  • The TTM is -592.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-592.0%TTM-592.0%0.0%
TTM-592.0%YOY-573.5%-18.5%
TTM-592.0%5Y-1,361.4%+769.4%
5Y-1,361.4%10Y-690.7%-670.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-592.0%-277.8%-314.2%
TTM-592.0%-279.2%-312.8%
YOY-573.5%-234.1%-339.4%
5Y-1,361.4%-388.9%-972.5%
10Y-690.7%-496.6%-194.1%
4.3.2.2. Operating Ratio

Measures how efficient Cardax Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 6.68 means that the operating costs are $6.68 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cardax Inc:

  • The MRQ is 6.683. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.683. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.683TTM6.6830.000
TTM6.683YOY6.735-0.052
TTM6.6835Y14.854-8.171
5Y14.85410Y7.687+7.167
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6832.761+3.922
TTM6.6833.321+3.362
YOY6.7353.430+3.305
5Y14.8545.021+9.833
10Y7.6876.570+1.117
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cardax Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cardax Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.11 means the company has $0.11 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cardax Inc:

  • The MRQ is 0.106. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.106. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.106TTM0.1060.000
TTM0.106YOY0.195-0.089
TTM0.1065Y0.262-0.156
5Y0.26210Y1.170-0.908
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1063.734-3.628
TTM0.1063.909-3.803
YOY0.1954.740-4.545
5Y0.2625.955-5.693
10Y1.1706.303-5.133
4.4.3.2. Quick Ratio

Measures if Cardax Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cardax Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cardax Inc:

  • The MRQ is 0.002. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.002. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.002TTM0.0020.000
TTM0.002YOY0.028-0.026
TTM0.0025Y0.139-0.138
5Y0.13910Y1.033-0.894
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0023.134-3.132
TTM0.0023.444-3.442
YOY0.0284.693-4.665
5Y0.1395.867-5.728
10Y1.0336.479-5.446
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cardax Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cardax Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cardax Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 8.16 means that Cardax Inc assets are financed with 815.6% credit (debt) and the remaining percentage (100% - 815.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cardax Inc:

  • The MRQ is 8.156. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 8.156. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ8.156TTM8.1560.000
TTM8.156YOY4.566+3.590
TTM8.1565Y4.556+3.599
5Y4.55610Y4.134+0.423
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.1560.343+7.813
TTM8.1560.346+7.810
YOY4.5660.306+4.260
5Y4.5560.365+4.191
10Y4.1340.382+3.752
4.5.4.2. Debt to Equity Ratio

Measures if Cardax Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cardax Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cardax Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.005-0.005
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.395-0.395
TTM-0.450-0.450
YOY-0.372-0.372
5Y-0.449-0.449
10Y0.0050.488-0.483
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cardax Inc generates.

  • Above 15 is considered overpriced but always compare Cardax Inc to the Biotechnology industry mean.
  • A PE ratio of -0.27 means the investor is paying $-0.27 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cardax Inc:

  • The EOD is 0.000. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.270. Based on the earnings, the company is expensive. -2
  • The TTM is -0.270. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.270+0.270
MRQ-0.270TTM-0.2700.000
TTM-0.270YOY-0.008-0.262
TTM-0.2705Y-0.086-0.183
5Y-0.08610Y-0.050-0.036
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.335+2.335
MRQ-0.270-2.413+2.143
TTM-0.270-2.978+2.708
YOY-0.008-3.462+3.454
5Y-0.086-6.080+5.994
10Y-0.050-6.254+6.204
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cardax Inc:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.755. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.755. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.755+0.755
MRQ-0.755TTM-0.7550.000
TTM-0.755YOY-0.011-0.744
TTM-0.7555Y-0.189-0.566
5Y-0.18910Y-0.115-0.074
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-3.054+3.054
MRQ-0.755-3.229+2.474
TTM-0.755-3.575+2.820
YOY-0.011-4.723+4.712
5Y-0.189-8.076+7.887
10Y-0.115-8.636+8.521
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cardax Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.13 means the investor is paying $-0.13 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cardax Inc:

  • The EOD is 0.000. Based on the equity, the company is expensive. -2
  • The MRQ is -0.134. Based on the equity, the company is expensive. -2
  • The TTM is -0.134. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.134+0.134
MRQ-0.134TTM-0.1340.000
TTM-0.134YOY-0.006-0.128
TTM-0.1345Y-0.060-0.074
5Y-0.06010Y-0.047-0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0001.829-1.829
MRQ-0.1341.903-2.037
TTM-0.1342.225-2.359
YOY-0.0062.412-2.418
5Y-0.0603.546-3.606
10Y-0.0474.109-4.156
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2020-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,425
Total Liabilities11,623
Total Stockholder Equity-10,198
 As reported
Total Liabilities 11,623
Total Stockholder Equity+ -10,198
Total Assets = 1,425

Assets

Total Assets1,425
Total Current Assets1,122
Long-term Assets303
Total Current Assets
Cash And Cash Equivalents 19
Short-term Investments 0
Inventory 994
Other Current Assets 108
Total Current Assets  (as reported)1,122
Total Current Assets  (calculated)1,122
+/- 0
Long-term Assets
Property Plant Equipment 1
Intangible Assets 302
Long-term Assets  (as reported)303
Long-term Assets  (calculated)303
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,552
Long-term Liabilities1,072
Total Stockholder Equity-10,198
Total Current Liabilities
Short-term Debt 3,784
Short Long Term Debt 3,783
Accounts payable 1,689
Other Current Liabilities 235
Total Current Liabilities  (as reported)10,552
Total Current Liabilities  (calculated)9,492
+/- 1,060
Long-term Liabilities
Capital Lease Obligations 1
Long-term Liabilities Other 1,072
Long-term Liabilities  (as reported)1,072
Long-term Liabilities  (calculated)1,073
+/- 1
Total Stockholder Equity
Common Stock1
Retained Earnings -72,092
Capital Surplus 61,893
Total Stockholder Equity (as reported)-10,198
Total Stockholder Equity (calculated)-10,198
+/-0
Other
Capital Stock1
Cash and Short Term Investments 19
Common Stock Shares Outstanding 745
Common Stock Total Equity1
Current Deferred Revenue4,843
Liabilities and Stockholders Equity 1,425
Net Debt 4,765
Net Invested Capital -5,415
Net Tangible Assets -10,500
Net Working Capital -9,430
Property Plant and Equipment Gross 1
Short Long Term Debt Total 4,784



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
59
12
1,768
1,547
852
751
3,157
2,459
2,019
1,425
1,4252,0192,4593,1577518521,5471,7681259
   > Total Current Assets 
27
9
1,318
1,107
414
312
2,728
2,024
1,586
1,122
1,1221,5862,0242,7283124141,1071,318927
       Cash And Cash Equivalents 
22
8
222
36
323
158
2,237
244
19
19
19192442,23715832336222822
       Short-term Investments 
0
0
0
93
88
123
91
119
0
0
00119911238893000
       Net Receivables 
4
0
0
0
0
0
37
157
206
0
020615737000004
       Other Current Assets 
1
1
109
113
90
143
114
143
183
108
1081831431141439011310911
   > Long-term Assets 
32
4
451
440
438
439
429
435
433
303
303433435429439438440451432
       Property Plant Equipment 
0
2
26
21
14
8
2
0
12
1
11202814212620
       Goodwill 
30
0
0
0
0
0
0
0
0
0
00000000030
       Intangible Assets 
0
0
425
420
424
431
427
435
420
302
30242043542743142442042500
       Long-term Assets Other 
2
2
0
0
0
0
0
435
0
0
004350000022
> Total Liabilities 
3
21
14,705
4,762
4,600
4,636
4,562
5,994
9,218
11,623
11,6239,2185,9944,5624,6364,6004,76214,705213
   > Total Current Liabilities 
3
21
14,695
4,762
4,600
4,636
4,562
5,902
8,133
10,552
10,5528,1335,9024,5624,6364,6004,76214,695213
       Short-term Debt 
0
0
9,039
0
0
0
0
0
1,597
3,784
3,7841,597000009,03900
       Short Long Term Debt 
0
0
0
0
0
0
0
0
1,585
3,783
3,7831,58500000000
       Accounts payable 
2
4
5,633
642
663
657
603
1,996
1,544
1,689
1,6891,5441,9966036576636425,63342
       Other Current Liabilities 
1
17
23
4,120
3,937
3,979
3,959
3,906
827
235
2358273,9063,9593,9793,9374,12023171
   > Long-term Liabilities 
2
4
10
642
663
657
603
93
1,085
1,072
1,0721,085936036576636421042
       Other Liabilities 
0
0
10
0
0
0
86
93
84
72
728493860001000
> Total Stockholder Equity
56
-9
-12,936
-3,214
-3,748
-3,886
-1,405
-3,535
-7,199
-10,198
-10,198-7,199-3,535-1,405-3,886-3,748-3,214-12,936-956
   Common Stock
1
1
9
64
69
85
123
134
1
1
11134123856964911
   Retained Earnings Total Equity-72,092-67,036-61,943-57,919-55,934-54,150-49,892-32,89800
   Accumulated Other Comprehensive Income 000-30-24-18-49,8920-78-13
   Capital Surplus 
0
0
19,892
46,908
50,333
51,963
56,401
58,274
59,837
61,893
61,89359,83758,27456,40151,96350,33346,90819,89200
   Treasury Stock0000000000
   Other Stockholders Equity 
68
68
0
46,614
50,333
51,963
56,391
58,274
59,837
61,893
61,89359,83758,27456,39151,96350,33346,61406868



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2022-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue-
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense--
Operating Income-0
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = 0
0
0
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-0
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Cardax Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cardax Inc. The general trend of Cardax Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cardax Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cardax Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0002 < 0.0002 < 0.0002.

The bearish price targets are: 0.0002 > 0.0002 > 0.0002.

Tweet this
Cardax Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cardax Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cardax Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cardax Inc. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cardax Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cardax Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cardax Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Cardax Inc Daily Moving Average Convergence/Divergence (MACD) ChartCardax Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cardax Inc. The current adx is 70.50.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Cardax Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cardax Inc. The current sar is 0.00020149.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cardax Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cardax Inc. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Cardax Inc Daily Relative Strength Index (RSI) ChartCardax Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cardax Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cardax Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Cardax Inc Daily Stochastic Oscillator ChartCardax Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cardax Inc. The current cci is -66.66666667.

Cardax Inc Daily Commodity Channel Index (CCI) ChartCardax Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cardax Inc. The current cmo is 0.

Cardax Inc Daily Chande Momentum Oscillator (CMO) ChartCardax Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cardax Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Cardax Inc Daily Williams %R ChartCardax Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cardax Inc.

Cardax Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cardax Inc. The current atr is 0.

Cardax Inc Daily Average True Range (ATR) ChartCardax Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cardax Inc. The current obv is -155.

Cardax Inc Daily On-Balance Volume (OBV) ChartCardax Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cardax Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Cardax Inc Daily Money Flow Index (MFI) ChartCardax Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cardax Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

Cardax Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cardax Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cardax Inc with someone you think should read this too:
  • Are you bullish or bearish on Cardax Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cardax Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cardax Inc

I send you an email if I find something interesting about Cardax Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cardax Inc.

Receive notifications about Cardax Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.